A Next Generation of Pneumococcal Disease Protection

Target Audience
This activity is intended for infectious disease specialists, primary care physicians, advanced practice providers, pharmacists, nurses and other clinicians who manage adult patients for whom pneumococcal vaccination is recommended.

Program Overview
In this modular video-based activity, multidisciplinary faculty provide their perspectives on the changing epidemiology of pneumococcal disease and the protection afforded by a next generation of conjugate vaccines. Hear expert insights on considerations for next generation pneumococcal vaccine use, patient access, and strategies for engaging patients. Two case studies are discussed to drive home practical strategies to use in day-to-day practice.

Learning Objectives
Upon completion of this activity, participants should be able to:

Explain the rationale behind the development of next generation pneumococcal conjugate vaccines
Identify highest-risk groups who should receive PCV15 versus PCV20
Formulate strategies to engage patients in shared clinical decision-making per CDC recommendations